SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001438133-20-000032
Filing Date
2020-04-15
Accepted
2020-04-14 18:26:04
Documents
10
Period of Report
2020-03-31
Effectiveness Date
2020-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A PROXY STATEMENT a2020proxy-tndmdef14a.htm DEF 14A 1106714
2 a2019installedbasechart.jpg GRAPHIC 68791
3 a2019salesgrowthcharta01.jpg GRAPHIC 54256
4 a2019stockpricechart.jpg GRAPHIC 52950
5 a2020tandemproxybackcoverlow.jpg GRAPHIC 306433
6 a2020tandemproxyfrontcoverlo.jpg GRAPHIC 328653
7 instr1.jpg GRAPHIC 199124
8 instr2.jpg GRAPHIC 95384
9 jssignature.jpg GRAPHIC 60024
10 jssignaturea01.jpg GRAPHIC 60024
  Complete submission text file 0001438133-20-000032.txt   2785541
Mailing Address 11075 ROSELLE STREET San Diego CA 92121
Business Address 11075 ROSELLE STREET San Diego CA 92121 858-366-6900
TANDEM DIABETES CARE INC (Filer) CIK: 0001438133 (see all company filings)

IRS No.: 204327508 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36189 | Film No.: 20792286
SIC: 3841 Surgical & Medical Instruments & Apparatus